Literature DB >> 12906029

Different long-term course between chest pain and exercise-induced ST depression in syndrome X.

Satoshi Shintani1, Yasuhiro Nishiyama, Kiichiro Yamamoto, Yoshinori Koga.   

Abstract

The aim of the present study was to assess the long-term clinical course of patients with syndrome X, focusing on different courses between exercise-induced ST depression and chest pain. Forty-three patients with syndrome X were followed up for 6.4 +/- 3.8 years. They were divided into the 3 groups according to chest pain: disappeared (n = 24), improved (n = 14), or unchanged (n = 5). No patients had cardiac events and all had a favorable long-term prognosis. In patients showing disappearance of chest pain, exercise-induced ST depression and rate-pressure product (RPP) at peak exercise did not change during follow-up. However, ST depression and RPP decreased significantly in those with improved chest pain. These observations suggest that abnormal pain perception plays an important role in the development of chest pain.

Entities:  

Mesh:

Year:  2003        PMID: 12906029     DOI: 10.1536/jhj.44.471

Source DB:  PubMed          Journal:  Jpn Heart J        ISSN: 0021-4868


  3 in total

1.  Long-term prognosis of patients with cardiac syndrome X: a review.

Authors:  I A C Vermeltfoort; G J J Teule; A B van Dijk; H J Muntinga; P G H M Raijmakers
Journal:  Neth Heart J       Date:  2012-09       Impact factor: 2.380

2.  Chest Pain Characteristics in Cardiac Syndrome X Compared to Coronary Artery Disease.

Authors:  Ramaze Farouke Elhakeem; Mohamed Faisal Lutfi; Ahmed Babiker Mohamed Ali; Mohamed Yusif Sukkar
Journal:  Open Access Maced J Med Sci       Date:  2019-07-25

3.  Guidelines for reasonable and appropriate care in the emergency department (GRACE): Recurrent, low-risk chest pain in the emergency department.

Authors:  Paul I Musey; Fernanda Bellolio; Suneel Upadhye; Anna Marie Chang; Deborah B Diercks; Michael Gottlieb; Erik P Hess; Michael C Kontos; Bryn E Mumma; Marc A Probst; John H Stahl; Jason P Stopyra; Jeffrey A Kline; Christopher R Carpenter
Journal:  Acad Emerg Med       Date:  2021-07-06       Impact factor: 5.221

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.